supportive and pivotal data needed to establish the effectiveness
of LHRHa to induce gamete maturation in a variety of fish species.
Hormone - Releasing Hormone analogue
(des-Gly10, [D-Ala6] LH-RH
Ethylamide) - LHRHa
|Source of drug:
||1269 Lattimore Road
Ferndale, WA 98248 USA
||Attention: Jim Brackett
Toll Free: 800-283-5292
Injectable only, implants not permitted
||5 - 100
micrograms LHRHa per kilogram body weight
||Single or multiple treatment. Multiple treatment will generally
consist of a single "priming dose," followed by a single "resolving
dose." Administered IP or IM.
||14 days for all fish; no withdrawal period is required for injected fish that will
not be susceptible to legal harvest for at least
14 days post-treatment.
must collect data reporting percent ovulation and/or percent
spermiation in treated fish. Investigator should also report
general fish behavior and any adverse effects relating to treatment.
or restrictions on use:
must follow all instructions in the Study Protocol for INAD
8061 regarding drug acquisition and handling, fish treatment
and disposition, and data reporting requirements.
Use of LHRHa implants is not authorized
per facility per year
contact for other information:
Bonnie Johnson, FWS - AADAP
||Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.